D E Bergsagel

17 papers receiving 769 citations

Peers

D E Bergsagel
Comparison fields: 5 of 74
  • Hematology 487
  • Pathology and Forensic Medicine 258
  • Genetics 150
  • Oncology 299
  • Neurology 108
Replace G. J. Ossenkoppele with:
G. J. Ossenkoppele Netherlands
Jorge A. Spinolo United States
J. L. Harousseau France
F. R. Appelbaum United States
SN Wolff United States
S N Rabinowe United States
Burton J. Lee United States
Gregg A. Olsen United States
G. Ucci Italy
Ilse Christiansen Denmark
D E Bergsagel relative to G. J. Ossenkoppele Netherlands G. J. Ossenkoppele's profile →
Citations per field
00.5×1.5×1.9×
G. J. Ossenkoppele · 1×
Citations per year

Countries citing papers authored by D E Bergsagel

Since Specialization
Citations

This map shows the geographic impact of D E Bergsagel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D E Bergsagel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D E Bergsagel more than expected).

Fields of papers citing papers by D E Bergsagel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D E Bergsagel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D E Bergsagel. The network helps show where D E Bergsagel may publish in the future.

Co-authors

The 25 scholars most cited alongside D E Bergsagel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D E Bergsagel Line = papers co-authored together D E Bergsagel links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1 1983294
2
Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. IV. L-Phenylalanine mustard (NSC-8806).
196297
3 199178
4 198578
5 199255
6
Benzene and multiple myeloma: appraisal of the scientific evidence.
199939
7
Chromosome damage in murine and human cells following cytoxan therapy.
196236
8 197135
9 199232
10 198529
11 199128
12
Weekly cyclophosphamide and alternate-day prednisone: an effective secondary therapy in multiple myeloma.
19878
13 19917
14 19527
15
Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. V. 1-Aminocyclopentanecarboxylic acid (NSC-1026).
19624
16 19924
17
Differential effects of chemotherapeutic agents on mouse myeloma and hemopoietic stem cells. Abstr.
19721

About D E Bergsagel

D E Bergsagel is a scholar working on Hematology, Oncology, Pathology and Forensic Medicine, Neurology and Pulmonary and Respiratory Medicine, having authored 17 papers that have together received 832 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (7 papers), Lymphoma Diagnosis and Treatment (5 papers), Cancer Treatment and Pharmacology (3 papers), Lung Cancer Treatments and Mutations (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Phytochemical compounds biological activities (2 papers), Synthesis and biological activity (2 papers) and CNS Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Hematology (487 citations), Pathology and Forensic Medicine (258 citations), Genetics (150 citations), Oncology (299 citations) and Neurology (108 citations). D E Bergsagel has collaborated with scholars based in Canada, New Zealand and United States. Frequent co-authors include Margaret A. Knowling, Andrew R. Harwood, Kenneth M. Griffith, Christopher P. Austin, T. Chua, Simon Sutcliffe, HA Messner, MD Minden, Héctor Martínez-Valdez and R. S. Bush. Their work appears in journals such as Journal of Clinical Oncology, Blood, International Journal of Radiation Oncology*Biology*Physics, Annals of Internal Medicine and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact